Healio

FDA approves Hovilpri for herpes simplex virus lesions

The FDA has approved pritelivir to treat mucocutaneous lesions caused by herpes simplex virus in immunocompromised adult ...
Contemporary OB/GYN

FDA approves pritelivir tablets to treat lesions from HSV

The FDA has approved pritelivir (Hovilpri) tablets for adults with weakened immune systems who have mucocutaneous lesions ...
BIOENGINEER

Epithelial Cells’ Sensitivity to Interferon Gamma May Shape Genital Herpes Outcomes

New research in PLOS Pathogens shows that genital epithelial cells from people with asymptomatic HSV-2 infection respond more ...

AI tool designed and integrated into hospital workflows to classify skin lesions

Skin cancer is a global health challenge, with nearly 1.5 million new cases diagnosed in 2024, according to World Health ...